Markets.com Logo

KALY

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0$
  • Previous Close
    0$
  • 52 Week Change
    0.00$
  • Day Range
    0.00$
  • 52 Week High/Low
    0$ - 0.0001$
  • Dividend Per Share
    --
  • Market cap
    815 K$
  • EPS
    2.13
  • Beta
    -91.13
  • Volume
    --

About

KALY.US refers to Kalytera Therapeutics, Inc. It's a pharmaceutical company that focuses on developing and commercializing novel cannabinoid-based therapies for various diseases, including graft-versus-host disease and inflammatory bowel disease. The .US indicates that the stock is listed on a United States stock exchange.
DAX 30 technical outlook: What are the future predictions for the DAX?

DAX 30 technical outlook: What are the future predictions for the DAX?

Ghko B|--
Crypto Market Outlook 2026: BTC Eyes $100K–$200K, ETH Bullish Scenario, XRP Prediction

Crypto Market Outlook 2026: BTC Eyes $100K–$200K, ETH Bullish Scenario, XRP Prediction

Ghko B|--
XRP Price Prediction: Will XRP (Ripple) Outperform Bitcoin (BTC/USD) in 2026?

XRP Price Prediction: Will XRP (Ripple) Outperform Bitcoin (BTC/USD) in 2026?

Ghko B|--
Stock market analysis: Dow Jones (DJIA), S&P 500 and Nasdaq close higher today

Stock market analysis: Dow Jones (DJIA), S&P 500 and Nasdaq close higher today

Frances Wang|--
Oil prices spike over $110: Will oil prices keep going up amid Middle East crisis?

Oil prices spike over $110: Will oil prices keep going up amid Middle East crisis?

Ghko B|--
Stellar (XLM) price analysis: Will XLM/USD reach $1 in 2026?

Stellar (XLM) price analysis: Will XLM/USD reach $1 in 2026?

Ghko B|--
Crude oil prices continue to rise: How long could Middle East tensions keep international oil prices high?

Crude oil prices continue to rise: How long could Middle East tensions keep international oil prices high?

Ghko B|--

Factors

Clinical Trial Results: Positive data from clinical trials for Kalytera's drug candidates can drive stock prices up, while negative results often lead to a decrease.

Regulatory Approvals: Approvals from regulatory bodies like the FDA can significantly increase stock value, while rejections can cause it to plummet.

Market Sentiment: Overall investor optimism or pessimism towards the biotech sector or Kalytera specifically influences trading volume and stock price.

Financial Performance: Company revenues, profitability, and cash flow impact investor confidence and influence stock valuation.

Competition: The presence of competing therapies or companies in the same therapeutic area can affect Kalytera's market share and stock price.

Partnerships & Acquisitions: Strategic collaborations or potential acquisitions can boost stock prices due to increased resources and market access.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Ghko B|--
CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

Ghko B|--
CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

Ghko B|--